Composite hydrogel and preparation method thereof

By combining polyethylene glycol diacrylate, alginate and collagen in the hydrogel, a stable three-dimensional structure is solved, and the problem that existing hydrogels cannot significantly improve cell biological activity is achieved, and cell proliferation and wounds are achieved Significant promotion of healing.

CN118987239APending Publication Date: 2024-11-22THE CHINESE UNIVERSITY OF HONG KONG
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411091220.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

When existing hydrogels are used in carrier cells, they cannot significantly improve the biological activity and proliferation ability of cells, which affects their application in the field of biomedical science.

Method used

Using a multivariate and collaborative design composite hydrogel, including polyethylene glycol diacrylate, alginate and collagen, it forms a stable three-dimensional network structure through photocrosslinking and chemical crosslinking, providing a suitable growth environment and promoting cell proliferation and differentiation.

Benefits of technology

It significantly improves the biological activity and antioxidant damage ability of mesenchymal stem cells, has good mechanical and stability, and promotes skin wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004986650200000011
    Figure HDA0004986650200000011
  • Figure HDA0004986650200000012
    Figure HDA0004986650200000012
  • Figure HDA0004986650200000021
    Figure HDA0004986650200000021
Patent Text Reader

Abstract

The invention discloses composite hydrogel containing polyethylene glycol diacrylate, alginate and collagen and a preparation method of the composite hydrogel, and relates to the field of biological materials. Through multi-element collaborative design of components of the composite hydrogel, proliferation of the mesenchymal stem cells can be promoted after the composite hydrogel is loaded with the mesenchymal stem cells, and the oxidative damage resistance is enhanced. Wherein the polyethylene glycol diacrylate provides mechanical support and stability, the alginate provides packaging and protection for the mesenchymal stem cells, and the collagen enhances cell adhesion and promotes cell proliferation. Experimental results show that after the composite hydrogel is loaded with the mesenchymal stem cells, proliferation of the mesenchymal stem cells can be promoted, the biological activity and the oxidative damage resistance of the mesenchymal stem cells are improved, and the composite hydrogel has good mechanical property and stability and meanwhile has an obvious promoting effect on skin wound healing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biomaterials, and in particular to a composite hydrogel and a preparation method thereof. Background Art

[0002] In recent years, many researchers at home and abroad have discovered that mesenchymal stem cells (MSCs), as a pluripotent stem cell with the ability of self-renewal and multidirectional differentiation, have the advantages of easy collection, wide source, low immunogenicity and no ethical restrictions. They show good therapeutic potential in skin damage repair, immune regulation and gene modification.

[0003] Using polymer materials as biological scaffolds to load stem cells has become a common method in the field of regenerative medicine and tissue engineering. As a new type of biomedical carrier, hydrogel has great application prospects and huge potential in the field of loading MSCs. It has some properties that other polymer materials do not have, such as: it can absorb water and swell in water without dissolving in water, it has porous properties, and can be used for tissue engineering and biodegradation. Current research on hydrogels is mostly about using it as a carrier to deliver cells or drugs, but the biological activity and proliferation ability of cells in it have not changed significantly, which will affect its application in the biomedical field. Summary of the invention

[0004] In view of this, the present invention provides a composite hydrogel and a preparation method thereof. The composite hydrogel provided by the present invention can promote the proliferation of mesenchymal stem cells, improve their biological activity and anti-oxidative damage ability, has good mechanical properties and stability, and has a significant promoting effect on skin wound healing.

[0005] The invention provides a composite hydrogel comprising polyethylene glycol diacrylate, alginate and collagen.

[0006] The present invention designs the components of the composite hydrogel through multiple coordinated designs, wherein polyethylene glycol diacrylate provides mechanical support and stability, alginate provides encapsulation and protection of mesenchymal stem cells, and collagen enhances cell adhesion and promotes cell proliferation. The three work synergistically to promote the proliferation ability and biological activity of mesenchymal stem cells in the composite hydrogel.

[0007] In the present invention, polyethylene glycol diacrylate has good biocompatibility and excellent mechanical properties, and can be used as a cell scaffold material to provide a suitable growth environment for cells and promote cell proliferation and differentiation. The present invention cross-links polyethylene glycol diacrylate by photocrosslinking to form a gel. In other specific implementations, the polyethylene glycol diacrylate can also form a gel by free radical polymerization.

[0008] The alginate of the present invention is a natural polysaccharide with good biocompatibility and biological activity. It can form a high viscosity solution in water, and further form a hydrogel with a stable three-dimensional network structure by chemical cross-linking, providing a suitable growth environment for cells and promoting cell proliferation and differentiation. In some specific implementations, the alginate can also be gelled by freezing-thawing, heat treatment, covalent cross-linking, etc. In some specific implementations, the alginate is selected from calcium alginate.

[0009] The collagen of the present invention is rich in a variety of bioactive factors, can promote cell adhesion, proliferation and differentiation, and is beneficial to tissue repair and regeneration. In the composite hydrogel provided by the present invention, collagen has good biocompatibility, can simulate the microenvironment of natural human tissue, and provide suitable growth and repair conditions for cells. In some specific implementations, the collagen is selected from collagen type I or collagen type II, preferably collagen type I. The structural support and toughness of collagen type I are better than those of collagen type II, and it is more widely distributed in the body and easier to obtain.

[0010] In some specific implementations, the mass ratio of polyethylene glycol diacrylate, alginate and collagen is (120-180): (20-30): (0.35-0.53), preferably (120-160): (20-25): (0.35-0.47), and more preferably (120-140): (20-25): (0.35-0.41).

[0011] In some specific implementations, the composite hydrogel provided by the present invention further includes mesenchymal stem cells. The present invention uses the composite hydrogel to load mesenchymal stem cells, which can promote the proliferation of mesenchymal stem cells and improve their biological activity and anti-oxidative damage ability.

[0012] In some specific implementations, the concentration of the mesenchymal stem cells in the composite hydrogel is (5-20)×10 6 / mL, preferably (5-15)×10 6 / mL, more preferably (7-13)×10 6 In some specific implementations, the mesenchymal stem cells are selected from umbilical cord mesenchymal stem cells, bone marrow mesenchymal stem cells or adipose mesenchymal stem cells, preferably umbilical cord mesenchymal stem cells or bone marrow mesenchymal stem cells, more preferably umbilical cord mesenchymal stem cells.

[0013] When polyethylene glycol diacrylate (PEGDA), sodium alginate and collagen are combined in a hydrogel preparation for wound healing, the following advantages will occur:

[0014] 1. Enhanced biocompatibility: PEGDA, sodium alginate and collagen are biocompatible materials that ensure minimal immune response and compatibility with surrounding tissues. In addition, collagen, as a major component of the extracellular matrix (ECM), promotes cell adhesion, migration and proliferation. By incorporating collagen into the hydrogel, it creates a bioactive environment that supports stem cell attachment and function, thereby enhancing the wound healing process.

[0015] 2. Structural and mechanical similarity to natural tissue: The combination of PEGDA, sodium alginate and collagen enables the hydrogel to mimic the structural and mechanical properties of natural tissue. Compared with sodium alginate alone, PEGDA hydrogel is able to retain more water. This water retention property helps create a moist environment at the wound site by promoting cell migration, angiogenesis and the formation of granulation tissue. This tissue similarity also provides support and stability for the loaded stem cells, promoting their survival and growth at the wound site.

[0016] 3. Versatile and customizable: The combination of PEGDA, sodium alginate and collagen allows for flexibility in hydrogel formulation and customization. PEGDA and sodium alginate can be easily mixed and prepared as an injectable solution. This feature facilitates easy handling and application of the hydrogel, making it suitable for a variety of wound shapes and sizes. It can also load various types of stem cells, secreted proteins or exosomes according to the specific requirements of the wound healing process.

[0017] 4. Synergistic effect on tissue regeneration: PEGDA provides mechanical support and stability, sodium alginate provides encapsulation and protection of stem cells, and collagen enhances cell adhesion and promotes tissue regeneration. Together, they create an optimal microenvironment for loaded stem cells to promote wound healing. The combination of PEGDA and sodium alginate in the hydrogel also provides controlled degradation properties. This allows the hydrogel to gradually degrade over time, minimizing the need for removal and supporting tissue regeneration.

[0018] In summary, the combination of PEGDA, sodium alginate and collagen in hydrogels to load stem cells or secretomes has the advantages of enhanced biocompatibility, similarity to natural tissue structure, synergistic effect on tissue regeneration, and high plasticity. These characteristics make this hydrogel stem cell preparation have broad application prospects in the field of promoting skin wound healing.

[0019] The present invention also provides a method for preparing a composite hydrogel, comprising:

[0020] a) mixing polyethylene glycol diacrylate solution, alginate solution, collagen solution and mesenchymal stem cell solution uniformly;

[0021] b) cross-linking the mixed solution to obtain a composite hydrogel.

[0022] The present invention first prepares a polyethylene glycol diacrylate solution, an alginate solution, a collagen solution and a mesenchymal stem cell solution. In some specific implementations, the polyethylene glycol diacrylate solution is a polyethylene glycol diacrylate dissolved in a solvent to obtain a solution with a concentration of 5% to 25% (w / v), preferably 10% to 20% (w / v), and more preferably 10% to 15% (w / v). In some specific implementations, the solvent of the polyethylene glycol diacrylate solution is PBS buffer. In some specific implementations, the polyethylene glycol diacrylate solution also includes an initiator, and the mass ratio of the initiator to the polyethylene glycol diacrylate is 1:2 to 10, preferably 1:2 to 8, and more preferably 1:4 to 8. In some specific implementations, the initiator is selected from phenyl-2,4,6-trimethylbenzoyl lithium phosphite (LAP).

[0023] In some specific implementations, the alginate solution is obtained by dissolving alginate in a solvent, and the concentration of the alginate solution is 1% to 10% (w / v), preferably 1% to 8% (w / v), and more preferably 1% to 5% (w / v). In some specific implementations, the solvent of the alginate solution is selected from PBS buffer.

[0024] In some specific implementations, the collagen solution is a solution obtained by dissolving collagen in acetic acid, and the concentration of the collagen solution is 3-4 mg / mL, preferably 3.2 mg / mL-3.8 mg / mL. In some specific implementations, the concentration of the acetic acid is 0.005-0.05 M, preferably 0.01 M. In some specific implementations, the collagen solution is a collagen type I solution purchased from Corning, model 354236.

[0025] In some specific implementations, the concentration of the mesenchymal stem cell solution is (5-20)×10 6 / mL, preferably (5-15)×10 6 / mL, more preferably (7-13)×10 6 In some specific implementations, the solvent of the mesenchymal stem cell solution is PBS buffer. In some specific implementations, the mesenchymal stem cell solution can be a suspension obtained by resuspending cells. The present invention has no particular restrictions on the method for obtaining the mesenchymal stem cell solution.

[0026] After obtaining the polyethylene glycol diacrylate solution, alginate solution, collagen solution and mesenchymal stem cell solution, they are evenly mixed to obtain a mixed solution, and the polyethylene glycol diacrylate and alginate in the solution are cross-linked to obtain a composite hydrogel.

[0027] In some specific implementations, the cross-linking specifically includes:

[0028] b1) photo-crosslinking the mixed solution;

[0029] b2) chemically cross-linking the solution obtained in step b1), wherein the cross-linking agent of the chemical cross-linking is calcium chloride.

[0030] Specifically, after obtaining the mixed solution, it is transferred to a cell culture plate, and the polyethylene glycol diacrylate is first cross-linked by photocrosslinking. In some specific implementations, the photocrosslinking is performed by placing the mixed solution under ultraviolet light. In some specific implementations, the wavelength of the ultraviolet light is 300nm to 400nm, preferably 320nm to 380nm, and more preferably 340nm to 370nm. In some specific implementations, the light intensity of the ultraviolet light is 5mW / cm 2 ~20mW / cm 2 , preferably 8mW / cm 2 ~16mW / cm 2 , more preferably 8 mW / cm 2 ~14mW / cm 2 In some specific implementations, the photo-crosslinking time is 0.5 to 5 minutes, preferably 0.5 to 3 minutes, and more preferably 1 to 2 minutes.

[0031] After the photocrosslinking is completed in the present invention, the alginate is crosslinked by chemical crosslinking to finally obtain a composite hydrogel. In some specific implementations, the chemical crosslinking is to add a crosslinking agent to the mixed solution for crosslinking, and the crosslinking agent is preferably calcium chloride. In some specific implementations, the mass ratio of the calcium chloride to the alginate is 1:0.5-5, preferably 1:0.5-3, and more preferably 1:1-3. In some specific implementations, the time of the chemical crosslinking is 0.5-5 minutes, preferably 0.5-3 minutes, and more preferably 1-2 minutes.

[0032] After obtaining the composite hydrogel, it is preferably subjected to impurity removal to obtain a pure composite hydrogel. In some specific implementations, the impurity removal is performed by washing the hydrogel with a buffer solution for 2 to 6 times, preferably 3 to 5 times, and more preferably 3 to 4 times. In some specific implementations, the buffer solution is selected from a PBS buffer solution. The present invention has no particular restrictions on the impurity removal method.

[0033] The present invention can also use polyethylene glycol diacrylate solution, alginate solution and collagen solution as raw materials to form a composite hydrogel, and then mix them with a mesenchymal stem cell solution to obtain a composite hydrogel loaded with mesenchymal stem cells. The preparation method is similar to the above, and the present invention will not be repeated here.

[0034] Another aspect of the present invention provides the use of the composite hydrogel as a medicine for promoting wound healing.

[0035] When the composite hydrogel provided by the present invention is used for wound healing, polyethylene glycol diacrylate has water retention and mechanical support. The water retention can create a moist environment at the wound site to promote cell migration, angiogenesis and the formation of granulation tissue, and the mechanical support can improve the stability of the hydrogel; alginate provides encapsulation and protection of mesenchymal stem cells; collagen enhances cell adhesion and promotes cell proliferation, and they create a good biologically active environment for mesenchymal stem cells to promote wound healing.

[0036] In some specific implementations, the composite hydrogel can be loaded with different types of stem cells, secretory proteins or exosomes according to the specific requirements of wound healing. In some specific implementations, the polyethylene glycol diacrylate solution and the alginate solution can be pre-mixed and prepared as an injection solution. In some specific implementations, the degradation time of the composite hydrogel can be controlled by adjusting the ratio of polyethylene glycol diacrylate and alginate.

[0037] The present invention introduces polyethylene glycol diacrylate, alginate and collagen into the composite hydrogel, polyethylene glycol diacrylate plays a tissue support role, alginate provides protection for mesenchymal stem cells, collagen enhances biocompatibility, and the three work together. The composite hydrogel provided by the present application has similarity with natural tissue structure, adjustable mechanical properties, enhanced biocompatibility and high plasticity, and has a synergistic effect on tissue regeneration. After loading stem cells, it has the effect of promoting the proliferation and migration of vascular endothelial cells, keratinocytes and fibroblasts, thereby promoting angiogenesis, collagen synthesis and epidermal regeneration. The test results show that the composite hydrogel provided by the present invention can promote the proliferation of mesenchymal stem cells, improve their biological activity and antioxidant damage ability, have good mechanical properties and stability, and have a significant promoting effect on skin wound healing. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 The growth conditions of the SA / PEGDA / Col-I hydrogel and the SA / Col-I hydrogel loaded with stem cells of the present invention;

[0039] Figure 2The proliferation of stem cells loaded by UC / PEGDA+SA+Col-I hydrogel, UC / SA+Col-I hydrogel and UC / PEGDA+Col-I hydrogel of the present invention;

[0040] Figure 3 The cell viability of the stem cells loaded by the hydrogel in Example 1 of the present invention after oxidative damage in two-dimensional culture and three-dimensional culture;

[0041] Figure 4 is the compression modulus of the SA / PEGDA / Col-I hydrogel and the SA / Col-I hydrogel of the present invention;

[0042] Figure 5 : are the swelling curves of the SA / PEGDA / Col-I hydrogel and the SA / Col-I hydrogel of the present invention;

[0043] Figure 6 : is the stability performance test curve of SA / PEGDA / Col-I hydrogel and SA / Col-I hydrogel of the present invention;

[0044] Figure 7 These are photos of mouse wounds on days 0, 3, 7, and 11 after being treated with different hydrogels. DETAILED DESCRIPTION

[0045] It should be understood that the expression "one or more of..." includes each of the items recited after the expression individually and in various different combinations of two or more of the recited items, unless otherwise understood from the context and usage. The expression "and / or" in combination with three or more recited items should be understood to have the same meaning, unless otherwise understood from the context.

[0046] The use of the terms "comprising", "having" or "containing", including their grammatical synonyms, should generally be understood as open and non-restrictive, for example not excluding other unrecited elements or steps, unless otherwise specifically stated or otherwise understood from the context.

[0047] It should be understood that the order of steps or the order in which certain actions are performed is not important as long as the present invention remains operable. In addition, two or more steps or actions may be performed simultaneously.

[0048] The use of any and all examples or exemplary language, such as "for example" or "including", herein is intended only to better illustrate the invention and does not limit the scope of the invention unless otherwise claimed. No language in this specification should be construed as indicating that any non-claimed element is essential to the practice of the invention.

[0049] In addition, the numerical ranges and parameters used to define the present invention are approximate values, and the relevant values ​​in the specific embodiments have been presented as accurately as possible. However, any numerical value inherently inevitably contains standard deviations due to individual test methods. Therefore, unless otherwise expressly stated, it should be understood that all ranges, quantities, values ​​and percentages used in this disclosure are modified by "about". Here, "about" generally means that the actual value is within plus or minus 10%, 5%, 1% or 0.5% of a specific value or range.

[0050] The present invention is further described below in conjunction with the following examples. The protection scope of the present invention is not limited by the following examples.

[0051] Example 1

[0052] (1) Preparation of polyethylene glycol diacrylate (PEGDA) solution: Under a sterile environment, dissolve 20 mg of photoinitiator LAP (lithium phenyl (2,4,6-trimethylbenzoyl) phosphinate, EFL-LAP-1g) in 10 ml of PBS buffer, then add 120 mg of PEGDA and fully dissolve to obtain a 12% (w / v) PEGDA solution, which is stored in the dark;

[0053] (2) Preparation of sodium alginate solution: Under a sterile environment, dissolve 20 mg of sodium alginate in 10 ml of PBS buffer and mix well to obtain a 2% (w / v) sodium alginate solution;

[0054] (3) Preparation of mesenchymal stem cell (MSCs) suspension: Under sterile conditions, resuspend 1×10 6 Human umbilical cord mesenchymal stem cells, to obtain a human umbilical cord mesenchymal stem cell suspension;

[0055] (4) Preparation of PEGDA / sodium alginate / collagen composite hydrogel: Under a sterile environment, PEGDA solution, sodium alginate solution, collagen type I solution (Corning, 354236), and human umbilical cord mesenchymal stem cell suspension were mixed at a volume ratio of 100:100:1:20 to make the final concentration of MSCs about 1×10 7 Transfer 100 μl of the mixed gel solution to a 6-well plate and place it under a wavelength of 365 nm and a light intensity of 10 mW / cm 2 The mixture was reacted under ultraviolet light for 2 minutes to cross-link PEGDA, and then 1 ml of calcium chloride solution (100 mM) was added to react for 2 minutes to cross-link sodium alginate. Finally, the mixture was washed three times with PBS buffer to obtain PEGDA / sodium alginate / collagen composite hydrogel.

[0056] Comparative Example 1

[0057] Under a sterile environment, the sodium alginate solution, collagen type I solution, and human umbilical cord mesenchymal stem cell suspension prepared in Example 1 were mixed at a volume ratio of 200:1:20 to make the final concentration of MSCs about 1×10 7 100 μl of the mixed gel solution was transferred to a 6-well plate, and 1 ml of calcium chloride solution (100 mM) was added to react for 2 minutes to cross-link the alginate, and finally washed 3 times with PBS buffer to obtain sodium alginate / collagen hydrogel.

[0058] Comparative Example 2

[0059] Under a sterile environment, the PEGDA solution, collagen type I solution, and human umbilical cord mesenchymal stem cell suspension prepared in Example 1 were mixed at a volume ratio of 200:1:20 to make the final concentration of MSCs about 1×10 7 Transfer 100 μl of the mixed gel solution to a 6-well plate and place it under a wavelength of 365 nm and a light intensity of 10 mW / cm 2 The PEGDA / collagen hydrogel was obtained by reacting under ultraviolet light for 2 minutes for cross-linking and finally washing with PBS buffer for 3 times.

[0060] Example 2

[0061] 5 μl of the mixed gel solution of Example 1 and Comparative Example 1 were taken and recorded as SA / PEGDA / Col-I group and SA / Col-I group in order, and added to 96-well plates for cross-linking reaction. After completion, they were washed three times with PBS buffer to obtain two groups of composite hydrogels loaded with stem cells. 100 μl of Dulbecco's Modified Eagle Medium (DMEM) complete culture medium (90% DMEM (Gibco), 10% fetal bovine serum (FBS), 1×10 6 U / L penicillin (Hyclone) and 100 mg / L streptomycin (Hyclone)) were added and cultured in a cell culture incubator. The absorbance values ​​on the 0th and 3rd days of culture were quantitatively detected by MTS method according to the instructions.

[0062] Figure 1Figure 1 shows the growth of stem cells in the SA / Col-I group and the SA / PEGDA / Col-I group with the same number of stem cells, where Figures a and b show the growth of stem cells on day 0, and Figures c and d show the growth of stem cells on day 3. It can be seen that under the same number of loaded cells and culture conditions, the growth and survival of stem cells in the SA / PEGDA / Col-I group on day 3 were significantly better than those in the SA / Col-I group.

[0063] Example 3

[0064] 5 μl of the mixed gel solution prepared in Example 1, Comparative Example 1 and Comparative Example 2 were added to a 96-well plate for photocrosslinking and chemical crosslinking reactions. After the reaction was completed, the plates were washed three times with PSB buffer solution to obtain three groups of composite hydrogels loaded with stem cells, which were sequentially recorded as UC / PEGDA+SA+Col-I group, UC / SA+Col-I group and UC / PEGDA+Col-I group. 100 μl of DMEM complete medium was added to each of the three groups of composite hydrogels and cultured in a cell culture incubator. The absorbance values ​​on the 0th, 4th and 8th days of culture were quantitatively detected by the MTS method according to the instructions.

[0065] Figure 2 The proliferation of stem cells in the UC / PEGDA+SA+Col-I group, UC / SA+Col-I group, and UC / PEGDA+Col-I group. It can be observed that as the culture time increases, the proliferation of stem cells in the UC / PEGDA+SA+Col-I group hydrogel is significantly better than that in the other two hydrogels.

[0066] Example 4

[0067] 5 μl of the hydrogel mixed solution of Example 1 loaded with stem cells was added to a 96-well plate, and after the cross-linking reaction was completed, it was washed three times with PBS buffer, and 100 μl of DMEM serum-containing medium was added; then, 5×10 3 UCMSCs were added to a 96-well plate at a density of 100 μl DMEM containing serum. After 24 hours, the medium was removed and replaced with 100 μl DMEM complete medium containing 300 mM hydrogen peroxide for 2 hours. The absorbance values ​​at the 0th and 2nd hour of treatment were quantitatively detected by MTS method according to the instructions, and recorded as CTRL group and H2O2 group.

[0068] Figure 3The figure shows the activity of stem cells under two-dimensional culture (cell adherent culture) and three-dimensional culture (cell culture in hydrogel), where two-dimensional culture is recorded as 2D group and three-dimensional culture is recorded as 3D (PEGDA + SA + Col-I) group. It can be seen that after hydrogen peroxide-induced cell damage, the cell activity of the hydrogel stem cells in Example 1 under three-dimensional culture conditions is significantly better than that under two-dimensional culture.

[0069] Example 5

[0070] Take 100 μl of each of the composite hydrogels of Example 1 and Comparative Example 1, and record them as SA / PEGDA / Col-I group and SA / Col-I group in order. Place the two groups of composite hydrogels on the flat fixture of the compression tester, and apply pressure to them at a compression speed of 1 mm / min until the hydrogel is destroyed. During the experiment, the data of compression force and compression deformation are recorded in real time, and the compression modulus of the hydrogel is calculated.

[0071] Figure 4 is the compression modulus of the SA / PEGDA / Col-I and SA / Col-I composite hydrogels. The SA / Col-I composite hydrogel has a higher compression modulus, indicating that it has higher stiffness and compressive resistance, while the SA / PEGDA / Col-I composite hydrogel has a lower compression modulus, indicating that it is more flexible and compliant, which can reduce the discomfort caused by contact with the organism.

[0072] Example 6

[0073] 100 μl of each of the hydrogels of Example 1 and Comparative Example 1 were prepared and recorded as SA / PEGDA / Col-I group and SA / Col-I group in order. Their initial weights were weighed and recorded as M0 and M0'. The two groups of composite hydrogels were immersed in PBS buffer and taken out every 24 hours. The surface moisture was absorbed with slightly moistened filter paper and the weights were weighed and recorded as M0. t and M t '. The swelling ratios of the two groups of composite hydrogels were calculated according to the formula: Swelling ratio (%) = (M t -–M0) / M0×100%, the swelling degree of the hydrogel reflects its hydrophilicity and dimensional stability.

[0074] like Figure 5 As shown in the figure, both groups of composite hydrogels can swell rapidly in PBS buffer, indicating that both have good water absorption properties. Among them, the swelling rate of the SA / PEGDA / Col-I group of composite hydrogels is significantly greater than that of the SA / Col-I group, indicating that it has stronger water absorption properties.

[0075] Example 7

[0076] 100 μl of each composite hydrogel of Example 1 and Comparative Example 1 were prepared and recorded as SA / PEGDA / Col-I group and SA / Col-I group in sequence. The initial weights were weighed and recorded respectively, and then immersed in water. The composite hydrogels were taken out every 24 hours, and the surface moisture was absorbed with slightly moistened filter paper. The weights were weighed and compared with the initial weights.

[0077] like Figure 6 As shown, the weight of the two groups of composite hydrogels remained stable in water, indicating that they have good application potential and long-term stability in aqueous environments.

[0078] Example 8

[0079] In this experiment, 30 adult diabetic (db / db) mice (about 30g) were used to establish a wound model to evaluate the effect of the above-mentioned composite hydrogel on wound healing. The mice were anesthetized by inhaling 1% isoflurane through a ventilator, and their backs were depilated. Then, two circular, full-skin excision wounds (8mm in diameter) were created in the depilated area. After disinfection with 75% alcohol, 100μl of the above-mentioned composite hydrogel of Example 1 loaded with human umbilical cord mesenchymal stem cells was applied to the wound, recorded as the UCMSC+hydrogel group; at the same time, different control groups were set up, and 100μl PBS buffer, 100μl blank hydrogel and 100μl human umbilical cord mesenchymal stem cells (1×10 7 / mL), in order: Ctrl group, Hydrogel group and UCMSC group; photos were taken and the wounds and healing conditions were observed on days 0, 3, 7 and 11, and the promoting effect of hydrogel in each group on wound healing was evaluated.

[0080] Figure 7 Shown are the wound photos of mice on days 0, 3, 7, and 11. The wound areas of the UCMSC+hydrogel and UCMSC groups on days 3, 7, and 11 were significantly reduced compared with those on day 0. After day 11, the wounds of the UCMSC+hydrogel group were lighter in color and had smaller wound areas compared with the UCMSC group.

[0081] The above examples show that the hydrogel containing PEGDA, sodium alginate and collagen solution has the advantages of good mechanical properties, good water absorption, high stability and good biocompatibility after loading mesenchymal stem cells, which can promote the proliferation of mesenchymal stem cells and enhance the ability to resist oxidative damage; at the same time, it has a significant promoting effect on the healing of mouse skin wounds.

[0082] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A composite hydrogel, characterized in that: These include polyethylene glycol diacrylate, alginate, and collagen.

2. The composite hydrogel according to claim 1, characterized in that Also included are mesenchymal stem cells.

3. The composite hydrogel according to claim 2, characterized in that The mass ratio of polyethylene glycol diacrylate, alginate and collagen is (120-180): (20-30): (0.35-0.53).

4. The composite hydrogel according to claim 3, characterized in that The concentration of the mesenchymal stem cells is (5-20)×10 6 Pieces / mL.

5. The composite hydrogel according to claim 1, characterized in that The alginate is selected from calcium alginate.

6. The composite hydrogel according to claim 1, characterized in that The collagen is selected from collagen type I or collagen type II; The mesenchymal stem cells are selected from umbilical cord mesenchymal stem cells, bone marrow mesenchymal stem cells or adipose mesenchymal stem cells.

7. A method for preparing a composite hydrogel, characterized in that: include: a) mixing polyethylene glycol diacrylate solution, alginate solution, collagen solution and mesenchymal stem cell solution uniformly; b) cross-linking the mixed solution obtained in step a) to obtain a composite hydrogel.

8. The preparation method according to claim 7, characterized in that: The solvent of the polyethylene glycol diacrylate solution, the alginate solution and the mesenchymal stem cell solution in step a) is PBS buffer; and the solvent of the collagen solution is acetic acid.

9. The preparation method according to claim 8, characterized in that The crosslinking in step b) is specifically: b1) photocrosslinking the mixed solution obtained in step a); b2) chemically cross-linking the solution obtained in step b1).

10. Use of the composite hydrogel according to any one of claims 1 to 6 in the preparation of a drug for promoting the healing of skin injuries.

Citation Information

Cited By

  • Composite hydrogel with biological activity, scaffold and application of composite hydrogel

    CN119119709A

  • Preparation method of 3D amniotic mesenchymal stem cells for improving premature ovarian failure

    CN121249575A